Back to School: How biopharma can reboot drug development. Access exclusive analysis here
Gene editing company CRISPR Therapeutics AG (Basel, Switzerland) named Marc Becker CFO. He was CFO and SVP at rEVO Biologics Inc. (Framingham, Mass.). CRISPR also named Tony Coles, the chairman and CEO
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury